SCHEDULE: HOLD Alapkezelo Zrt. Discloses 8.1% Stake in MediWound

Hungarian investment fund HOLD Alapkezelo Zrt. has reported a beneficial ownership of 8.1% in MediWound Ltd., holding 1,039,954 common shares.

Summary

• HOLD Alapkezelo Zrt., a Hungarian investment fund management company, has filed a Schedule 13G, indicating a significant ownership position.
• The filing reports beneficial ownership of 1,039,954 common shares of MediWound Ltd.
• This stake represents approximately 8.1% of MediWound Ltd.'s common stock outstanding.
• The percentage is calculated based on 12,835,186 shares outstanding as of January 16, 2026, as reported in MediWound's 6-K filing on January 15, 2026.
• HOLD Alapkezelo Zrt. holds sole voting power and sole dispositive power over all 1,039,954 shares.
• The reporting person certifies that the securities were not acquired for the purpose of changing or influencing control of MediWound Ltd.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a new significant institutional investor taking an 8.1% stake typically signals confidence in the company's value proposition and future prospects.

Positives

• A significant institutional investor, HOLD Alapkezelo Zrt., has taken an 8.1% stake in MediWound Ltd., which can be interpreted as a vote of confidence in the company's prospects.

Future Outlook

This filing does not provide forward-looking statements or guidance from MediWound Ltd. or the reporting person regarding MediWound's future.

Industry Context

StockSavvy.ai notes that the disclosure of a significant stake by an institutional investor like HOLD Alapkezelo Zrt. can often be interpreted by the market as a vote of confidence in the issuer's long-term strategy and potential within its sector, particularly in the biotechnology or medical device industry where MediWound operates.

Stakeholder Impact

• Shareholders: The entry of a new significant institutional investor may be viewed positively, potentially increasing investor confidence and liquidity.
• Management: May feel increased scrutiny or validation from a large institutional holder, though the filing states no intent to influence control.

Key Dates

Recommendation

While the disclosure of a new 8.1% institutional stake by HOLD Alapkezelo Zrt. in MediWound Ltd. is generally a positive signal, indicating investor confidence, the filing itself does not provide new operational or financial data to warrant a 'buy' recommendation. It primarily confirms a significant ownership position. Investors should 'hold' and monitor future company performance and further disclosures for more comprehensive investment decisions.

Keywords

MediWound Ltd., HOLD Alapkezelo Zrt., Schedule 13G, Beneficial Ownership, Common Shares, Institutional Investment, M68830104, Equity Stake, Investment Fund